• Journal Article

Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alheimer's disease: A systematic review and meta-analysis.

Citation

Hansen, R. A., Gartlehner, G., Webb, A. P., Morgan, C., & Moore, C. (2008). Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alheimer's disease: A systematic review and meta-analysis. Clinical Interventions in Aging, 3(2), 1 - 15.

Abstract